First Affiliated Hospital of Nanjing Medical University Researchers Add New Findings in the Area of Non-Small Cell Lung Cancer (Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer)

Source :: Immunotherapy Weekly. March 30, 2022, 2658
Publication Year :: 2022
Abstract: 2022 MAR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on non-small cell lung cancer are presented in a new report. According to [...]

Subjects :: Genetic aspects
Reports
Apoptosis -- Reports -- Genetic aspects
Cancer research -- Reports -- Genetic aspects
Biochemistry -- Genetic aspects -- Reports
Small cell lung cancer -- Genetic aspects
Immunotherapy -- Reports
Non-small cell lung cancer -- Genetic aspects
Biological markers -- Reports -- Genetic aspects
Oncology, Experimental -- Reports -- Genetic aspects
Lung cancer, Small cell -- Genetic aspects
Lung cancer, Non-small cell -- Genetic aspects
Cancer -- Research

Tools